Verona Pharma plc buy Piper Sandler
Start price
23.06.25
/
50%
€0.51
Target price
23.06.26
€139.15
Performance (%)
-
End price
24.06.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | 1,84 % | 1,39 % | 8,65 % |
| iShares Nasdaq 100 | 4,66 % | -1,80 % | 27,82 % |
| iShares Nikkei 225® | 3,96 % | -5,22 % | 51,81 % |
| iShares S&P 500 | 3,70 % | 1,58 % | 24,09 % |
Comments by Piper_Sandler for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) had its price target raised by analysts at Piper Sandler from $76.00 to $160.00. They now have an "overweight" rating on the stock.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten

